The value of MRD as a prognostic tool in myeloma VJHemOnc – Video Journal of Hematology & HemOnc 5:18 2 years ago 354 Далее Скачать
The importance of MRD as a prognostic tool in multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 1:36 1 year ago 146 Далее Скачать
The prognostic value of MRD in multiple myeloma & MRD-guided therapy VJHemOnc – Video Journal of Hematology & HemOnc 4:16 2 years ago 118 Далее Скачать
Where does MRD belong as a tool in myeloma? VJHemOnc – Video Journal of Hematology & HemOnc 4:10 3 years ago 195 Далее Скачать
Prognostic value of MRD and circulating plasma cells in myeloma VJHemOnc – Video Journal of Hematology & HemOnc 4:22 3 years ago 103 Далее Скачать
MRD as a prognostic tool but not for clinical decision-making in multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 1:37 2 years ago 127 Далее Скачать
Do any prognostic tools offer value in managing patients with Hodgkin lymphoma? HMP Education 15:36 6 years ago 131 Далее Скачать
Prognostic value of early bone marrow MRD status in CAR-T therapy for myeloma VJHemOnc – Video Journal of Hematology & HemOnc 1:27 2 years ago 117 Далее Скачать
The prognostic value of MRD negativity VJHemOnc – Video Journal of Hematology & HemOnc 3:14 2 years ago 29 Далее Скачать
MRD as a predictor of risk in myeloma VJHemOnc – Video Journal of Hematology & HemOnc 2:11 2 years ago 50 Далее Скачать
Prognostic value of early bone marrow MRD status in CAR-T therapy for multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 1:15 2 years ago 107 Далее Скачать
MRD2STOP: Can multimodal MRD negativity guide discontinuation of maintenance treatment in myeloma? International Myeloma Foundation 12:09 2 years ago 894 Далее Скачать
Mutations in MDS - Prognostic and Therapeutic Implications AAMDSIF 56:23 2 years ago 421 Далее Скачать
Clinical value of measurable residual disease assessment in multiple myeloma Labroots 58:04 3 years ago 161 Далее Скачать
Predictors of unsustained MRD negativity in multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 1:55 2 years ago 252 Далее Скачать
MRD negativity using deep sequencing is a major prognostic factor in myeloma VJHemOnc – Video Journal of Hematology & HemOnc 3:27 6 years ago 61 Далее Скачать
The main prognostic factors and why minimal residual disease is becoming crucial in multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 3:22 8 years ago 176 Далее Скачать
